CMV reactivation in ICU patients on ventilators for a week or more
Part of Lungs & breathing clinical trials.
This study looks at whether a common virus called cytomegalovirus (CMV) becomes active again in ICU patients who need a breathing machine for a week or more. It may help doctors understand who is at risk and how to better care for them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been on a breathing machine (ventilator) for at least 7 days.
- You have had a past infection with cytomegalovirus (CMV) shown by a positive blood test.
- You do not have a weakened immune system (e.g., from transplant, HIV, cancer, or long-term steroids).
- You have not taken antiviral medication in the last week.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often a common virus (CMV) becomes active again in children after a stem cell transplant from a donor. It will help doctors understand more about this risk and how to manage it.
This study looks at how often a common virus called CMV reactivates—meaning it becomes active again—in patients who receive CAR-T cell treatment for leukemia or lymphoma. It aims to understand the risks and help doctors better manage care.
This study checks whether a blood test (QuantiFERON-CMV, related to prior CMV infection) can predict if CMV might reactivate during a severe ulcerative colitis flare. It may help doctors spot people at higher risk and potentially guide monitoring and treatment during hospitalization.
This study looks at how the immune system reacts in ICU patients on a ventilator who have pneumonia. By measuring immune markers, the researchers hope to better understand and predict complications like ventilator-associated pneumonia.
This study looks at how having a weakened immune system affects the risk of getting infections with hard-to-treat bacteria in the ICU. Depending on your immune status, you may be placed in a group that helps doctors understand who is most at risk.
This trial tests whether using a blood test that measures your immune system's ability to fight CMV (a common virus) can guide when to stop anti-CMV drugs after a lung transplant, aiming to prevent the virus from causing disease.
Hear when a new Mechanical Ventilation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.